Literature DB >> 24216332

Complement C3 depletion links to the expansion of regulatory T cells and compromises T-cell immunity in human abdominal sepsis: a prospective pilot study.

Yujie Yuan1, Dongsheng Yan, Gang Han, Guosheng Gu, Jianan Ren.   

Abstract

PURPOSE: Complement depletion commonly occurred in septic patients, but this problem was often underestimated during the treatment process. This study was designed to determine the association between complement depletion and T-cell immunosuppression.
METHODS: From November 2011 to March 2012, patients with severe abdominal sepsis were prospectively enrolled in a single center. The baseline levels of complement C3 were used to stratify subjects into 2 groups. Plasma levels of complement components, percentage of regulatory T cells (Tregs), and T-cell immunity indexes were monitored at times after admission. The relationship between C3 depletion and T-cell response was investigated, with clinical outcomes explored meanwhile.
RESULTS: A total of 60 patients aged 43.9 ± 11.3 years were included within the period. C3 depletion, occurring in 65% of enrolled subjects, was strongly correlated with Treg expansion (P = .001) and decreased CD4(+)/CD8(+) ratio (P = .008). This depletion was also related to prolonged hospital stay (P = .001), delayed time to operation (P < .001), increased postoperative complications (P = .036), and hospital expenditure (P < .001).
CONCLUSIONS: Complement C3 depletion was found to be linked to the expansion of Tregs during abdominal sepsis. Such depletion and associated immunosuppression should be paid close attention in the critical care.
© 2013.

Entities:  

Keywords:  Adaptive immunity; Complement; Regulatory T cells; Sepsis

Mesh:

Substances:

Year:  2013        PMID: 24216332     DOI: 10.1016/j.jcrc.2013.09.007

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  9 in total

1.  The pattern recognition molecule collectin-L1 in critically ill children.

Authors:  Catherine Ingels; Ilse Vanhorebeek; Inge Derese; Lisbeth Jensen; Pieter J Wouters; Steffen Thiel; Greet Van den Berghe
Journal:  Pediatr Res       Date:  2016-04-08       Impact factor: 3.756

Review 2.  Impact of sepsis on CD4 T cell immunity.

Authors:  Javier Cabrera-Perez; Stephanie A Condotta; Vladimir P Badovinac; Thomas S Griffith
Journal:  J Leukoc Biol       Date:  2014-05-02       Impact factor: 4.962

Review 3.  Complement modulation of T cell immune responses during homeostasis and disease.

Authors:  Elizabeth V Clarke; Andrea J Tenner
Journal:  J Leukoc Biol       Date:  2014-09-10       Impact factor: 4.962

Review 4.  More than a Pore: Nonlytic Antimicrobial Functions of Complement and Bacterial Strategies for Evasion.

Authors:  Elisabet Bjanes; Victor Nizet
Journal:  Microbiol Mol Biol Rev       Date:  2021-01-27       Impact factor: 11.056

Review 5.  Activated Complement Factors as Disease Markers for Sepsis.

Authors:  Jean Charchaflieh; Julie Rushbrook; Samrat Worah; Ming Zhang
Journal:  Dis Markers       Date:  2015-09-02       Impact factor: 3.434

6.  Properdin levels in human sepsis.

Authors:  Cordula M Stover; John McDonald; Simon Byrne; David G Lambert; Jonathan P Thompson
Journal:  Front Immunol       Date:  2015-02-02       Impact factor: 7.561

7.  Prognostic Significance of Preoperative and Postoperative Complement C3 Depletion in Gastric Cancer: A Three-Year Survival Investigation.

Authors:  Jinning Ye; Yufeng Ren; Jianhui Chen; Wu Song; Chuangqi Chen; Shirong Cai; Min Tan; Yujie Yuan; Yulong He
Journal:  Biomed Res Int       Date:  2017-09-14       Impact factor: 3.411

Review 8.  Regulatory T cells in multiple sclerosis and myasthenia gravis.

Authors:  K M Danikowski; S Jayaraman; B S Prabhakar
Journal:  J Neuroinflammation       Date:  2017-06-09       Impact factor: 8.322

9.  Serum C1q Levels Have Prognostic Value for Sepsis and are Related to the Severity of Sepsis and Organ Damage.

Authors:  Huan Li; Juanjuan Chen; Yuanhui Hu; Xin Cai; Dongling Tang; Pingan Zhang
Journal:  J Inflamm Res       Date:  2021-09-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.